
Eproron 500mg Injection
Marketer
Kyna Pharmaceuticals
Salt Composition
Hydroxyprogesterone (500mg)
Overview Eproron 500mg Injection
Pregnant women at risk of preterm delivery may receive Eproron 500mg Injection to help prevent premature labor and subsequent preterm birth. This medication also reduces the likelihood of miscarriage in women with a history of premature birth. Administration is strictly by, or under the direct guidance of, a physician. Dosage and duration are determined solely by your doctor and must be followed precisely. Commonly reported side effects encompass injection site reactions, nausea, pruritus, diarrhea, and skin rash. Report any concerning side effects to your physician; management strategies may be available. Because Eproron 500mg Injection can influence blood glucose, regular monitoring is crucial. Immediately notify your doctor if you experience jaundice, darkened urine, or abdominal pain during treatment. Prior to commencing treatment, disclose any existing circulatory disorders, diabetes, liver conditions, or concurrent medications to your physician, as these factors can impact the drug's efficacy and mechanism of action.
Uses of Eproron 500mg Injection
Averting Preterm Birth
Major Benefits of Eproron 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Eproron 500mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Eproron 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Eproron 500mg Injection works:
Eproron injectable solution (500mg) contains a progestational agent.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eproron 500mg Injection is not advised; seek medical guidance before combining them.
PregnancySAFE IF PRESCRIBED
The injectable form of Eproron, 500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Eproron, 500mg, poses no known breastfeeding risks. Research in human subjects indicates minimal drug transfer to breast milk, suggesting no infant harm.
DrivingSAFE
Driving ability is typically unaffected by Eproron 500mg Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Eproron 500mg Injection to individuals with renal impairment. Physician consultation is advised. The drug's progesterone component may induce fluid retention in patients with pre-existing kidney conditions.
LiverUNSAFE
Individuals with hepatic impairment should likely abstain from Eproron 500mg Injection due to potential safety concerns. Medical advice is recommended.
What if you forget to take Eproron 500mg Injection :
Omit doses of Eproron 500mg Injection only after consulting your physician.
Facts to Know About Eproron 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, mineralocorticoids, and progestin derivatives |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Actions | First-generation progestins |
